Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Regular physical activity and adequate sleep also contribute to maintaining optimal levels
FDA approved in November 2023 The FDA recently approved a new Eli Lilly drug, Zepbound (tirzepatide), for chronic weight management in adults with at least one weight-related health condition
Research focus Triple-agonist metabolic peptide Appetite-signalling research Glucose-regulation pathways Body-composition and energy-metabolism studies Supplied by NOVATEC as a purity-tested, single-dose lyophilised vial
The medication slows gastric emptying and commonly causes gastrointestinal side effects including nausea, diarrhoea, and abdominal pain
It works by mimicking the action of a hormone that regulates appetite and food intake
A study conducted on pregnant mice, the species with a very similar biological and behavioral makeup to humans, also found that B12 deficiency led to high cholesterol levels and a significant increase in body fat percentage in pregnant mice
US$ 29.01
US$ 29.48
US$ 20.02
US$ 25.21
